当前位置：首页 SCI期刊 SCIE期刊医学中科院3区 JCRQ1 期刊介绍(非官网)

Pediatric DrugsSCIE

国际简称：PEDIATR DRUGS 参考译名：儿科药物

中科院分区
3区
CiteScore分区
Q1
JCR分区
Q1

基本信息：: ISSN：1174-5878; E-ISSN：1179-2019; 是否OA：未开放; 是否预警：否; TOP期刊：否

出版信息：: 出版地区：NEW ZEALAND; 出版商：Springer International Publishing; 出版语言：English; 出版周期：6 issues per year; 出版年份：1999; 研究方向：PEDIATRICS-PHARMACOLOGY & PHARMACY

评价信息：: 影响因子：3.4; H-index：55; CiteScore指数：7.2; SJR指数：1.017; SNIP指数：1.263

发文数据：: Gold OA文章占比：29.27%; 研究类文章占比：44.23%; 年发文量：52; 自引率：0; 开源占比：0.2356; 出版撤稿占比：0; 出版国人文章占比：0.02; OA被引用占比：0.2235...

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据中科院SCI分区 JCR分区发文数据常见问题

英文简介Pediatric Drugs期刊介绍

Pediatric Drugs promotes the optimization and advancement of all aspects of pharmacotherapy for healthcare professionals interested in pediatric drug therapy (including vaccines). The program of review and original research articles provides healthcare decision makers with clinically applicable knowledge on issues relevant to drug therapy in all areas of neonatology and the care of children and adolescents. The Journal includes:

-overviews of contentious or emerging issues.

-comprehensive narrative reviews of topics relating to the effective and safe management of drug therapy through all stages of pediatric development.

-practical reviews covering optimum drug management of specific clinical situations.

-systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.

-Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in the pediatric population.

-original research articles reporting the results of well-designed studies with a strong link to clinical practice, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic and pharmacoepidemiological studies.

Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Pediatric Drugs may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.

期刊简介Pediatric Drugs期刊介绍

《Pediatric Drugs》自1999出版以来，是一本医学优秀杂志。致力于发表原创科学研究结果，并为医学各个领域的原创研究提供一个展示平台，以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述，从广泛的视角提供当前感兴趣的研究主题的新见解，或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间： 12周，或约稿
医学
PEDIATRICS
SCIE
中科院3区
非预警

Cite Score数据（2024年最新版）Pediatric Drugs Cite Score数据

CiteScore：7.2
SJR：1.017
SNIP：1.263

学科类别	分区	排名	百分位
大类：Medicine 小类：Pediatrics, Perinatology and Child Health	Q1	27 / 330	91%
大类：Medicine 小类：Pharmacology (medical)	Q1	50 / 272	81%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Pediatric Drugs 中科院分区

中科院 2023年12月升级版 综述期刊：否 Top期刊：否

大类学科	分区	小类学科	分区
医学	3区	PEDIATRICS 儿科 PHARMACOLOGY & PHARMACY 药学	2区 3区

中科院分区表 是以客观数据为基础，运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据，得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次，类似于“优、良、及格”等。最开始，这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Pediatric Drugs JCR分区

2023-2024 年最新版

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：PEDIATRICS	SCIE	Q1	19 / 186	90.1%
学科：PHARMACOLOGY & PHARMACY	SCIE	Q2	105 / 354	70.5%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：PEDIATRICS	SCIE	Q1	39 / 186	79.3%
学科：PHARMACOLOGY & PHARMACY	SCIE	Q1	78 / 354	78.11%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2023-2024 年国家/地区发文量统计

国家/地区数量
USA72
Italy20
England13
Netherlands10
Belgium9
Canada9
Australia8
France6
New Zealand6
CHINA MAINLAND5

本刊中国学者近年发表论文

1、Trends in Adverse Drug Reactions Among Children: Evidence from Jiangsu Province of China, 2010-2019
Author: Xue, Hui; Li, Ming; Fan, Lijun; Du, Wei; Zou, Jianjun

Journal: PEDIATRIC DRUGS. 2023; Vol. 25, Issue 1, pp. 97-114. DOI: 10.1007/s40272-022-00539-6
2、Pharmacogenetic Aspects of Drug Metabolizing Enzymes and Transporters in Pediatric Medicine: Study Progress, Clinical Practice and Future Perspectives
Author: Zhao, Jinxia; Bian, Jialu; Zhao, Yinyu; Li, Yuanyuan; Liu, Boyu; Hao, Xu; He, Shiyu; Huang, Lin

Journal: PEDIATRIC DRUGS. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s40272-023-00560-3
3、Weight Gain and Other Metabolic Adverse Effects Associated with Atypical Antipsychotic Treatment of Children and Adolescents: A Systematic Review and Meta-analysis
Author: Noor B. Almandil, Ying Liu, Macey L. Murray, Frank M. C. Besag, Katherine J. Aitchison, Ian C. K. Wong

Journal: PEDIATRIC DRUGS, 2013, Vol.15, 139-150, DOI:10.1007/s40272-013-0016-6
4、The Role of Chemotherapy for Metastatic, Relapsed and Refractory Osteosarcoma
Author: Xin Xiao, Wei Wang, Zhen Wang

Journal: PEDIATRIC DRUGS, 2014, Vol.16, 503-512, DOI:10.1007/s40272-014-0095-z
5、Alternating Acetaminophen and Ibuprofen versus Monotherapies in Improvements of Distress and Reducing Refractory Fever in Febrile Children: A Randomized Controlled Trial
Author: Shuanghong Luo, Mengdong Ran, Qiuhong Luo, Min Shu, Qin Guo, Yu Zhu, Xiaoping Xie, Chongfan Zhang, Chaomin Wan

Journal: PEDIATRIC DRUGS, 2017, Vol.19, 479-486, DOI:10.1007/s40272-017-0237-1
6、Effectiveness and Safety of Different Once-Daily Doses of Adrenocorticotropic Hormone for Infantile Spasms
Author: Jinghua Yin, Qianjin Lu, Fei Yin, Ying Wang, Fang He, Liwen Wu, Lifen Yang, Xiaolu Deng, Chen Chen, Jing Peng

Journal: PEDIATRIC DRUGS, 2017, Vol.19, 357-365, DOI:10.1007/s40272-017-0225-5
7、Effect of Levocarnitine on the Therapeutic Efficacy of Conventional Therapy in Children with Dilated Cardiomyopathy: Results of a Randomized Trial in 29 Children
Author: Yuwen Wang, Yi Xu, Runmei Zou, Lijia Wu, Ping Liu, Hong Yang, Zhenwu Xie, Cheng Wang

Journal: PEDIATRIC DRUGS, 2018, Vol.20, 285-290, DOI:10.1007/s40272-018-0284-2
8、Method Development for Clinical Comprehensive Evaluation of Pediatric Drugs Based on Multi-Criteria Decision Analysis: Application to Inhaled Corticosteroids for Children with Asthma
Author: Yuncui Yu, Lulu Jia, Yao Meng, Lihua Hu, Yiwei Liu, Xiaolu Nie, Meng Zhang, Xuan Zhang, Sheng Han, Xiaoxia Peng, Xiaoling Wang

Journal: PEDIATRIC DRUGS, 2017, Vol.20, 195-204, DOI:10.1007/s40272-017-0278-5